Expression of AR is significantly associated with apocrine differentiation of salivary duct carcinomas [41] and breast cancers [42] indicating that AR is a surrogate marker for these histological types [43, 44], and possess a promising therapeutic target [45]. Here, AR is linked to breast cancer.